Hexarelin
Growth hormone axis · By Preptide Pro editorial team · Last updated
Hexarelin is a growth hormone axis peptide, and it is not FDA-approved. A synthetic hexapeptide that activates the ghrelin receptor. Studied in early human research on growth hormone release and the heart.
Not FDA-approvedChemistry (PubChem)
| PubChem CID | 6918297 |
|---|---|
| CAS number | 140703-51-1 |
| Molecular formula | C47H58N12O6 |
| Molecular weight | 887 g/mol |
| Other names | Hexarelin, Examorelin, EP-23905, examorelina, examoreline, MF-6003, examorelinum, EP23905 |
Is Hexarelin FDA-approved?
Not FDA-approved. No matching NDA or BLA was found in openFDA (Drugs@FDA).
How much research is there on Hexarelin?
PubMed lists 314 records for “hexarelin”, of which 59 are tagged as human clinical trials.
| Recent study | Journal | Date |
|---|---|---|
| Histopathological and immunohistochemical characterization of MPTP-associated pancreatic injury and its attenuation by Hexarelin in mice. | J Mol Histol | 2026 Sep 18 |
| Protective and restorative effects of hexarelin on MPTP-induced lung injury in mice. | J Basic Clin Physiol Pharmacol | 2026 Aug 21 |
| The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration. | Front Endocrinol (Lausanne) | 2026 |
| Hexarelin promotes the survival of retinal ganglion cells after optic nerve transection. | Indian J Pharmacol | 2026 Mar 1 |
| Identification of alexamorelin consumption biomarkers using human hepatocyte incubations and high-resolution mass spectrometry. | J Anal Toxicol | 2025 Jul 1 |
Sources
This is general research information, not medical advice. Check with a clinician before using any compound.